caseinFinding
Casein has no detected effect on adverse event occurrence (oral or enteral supplement)
no difference foundModerate evidenceFinding
01 · The sentence it was drawn from
“There was no significant difference in the incidence of adverse events between the two groups (MKP group; 65.0%, placebo group; 59.3%, p > 0.1).”
casein
Adverse event occurrence (oral or enteral supplement)
no difference found
- Who
- Healthy Japanese adults aged 20 to 74 with high-normal or elevated blood pressure, safety analysis set, 12 weeks
- Dose studied
- one sachet once daily containing 100 ug Met-Lys-Pro, taken with a drink, 12 weeks
Moderate evidencePMID 39275290 · 2024
02 · The study
- Study
- RCT
- Duration
- 3 months
Evidence, by strength
- strong
- moderatethis finding
- limited
- very limited
- insufficient
03 · The paper
Nutrients04 · To cite this finding
This address does not changehttps://catalystproject.ai/e/01M7EWQ8VD92D66C50F9HSR1VN